相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma
Jacob Jorns et al.
BJU INTERNATIONAL (2012)
Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
M. de Martino et al.
BRITISH JOURNAL OF CANCER (2012)
The role of pharmacogenomics in metastatic renal cell carcinoma
Daniel Castellano et al.
CANCER AND METASTASIS REVIEWS (2012)
Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
Janice A. Nagy et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence
David Paez et al.
CLINICAL CANCER RESEARCH (2012)
Current Treatment Considerations in Metastatic Renal Cell Carcinoma
Housam Haddad et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
Hai T. Tran et al.
LANCET ONCOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell Carcinomas
Luciana Schultz et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Adverse events from targeted therapies in advanced renal cell carcinoma: the impact on long-term use
Ziya Kirkali
BJU INTERNATIONAL (2011)
Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials
Chris Coppin et al.
BJU INTERNATIONAL (2011)
Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib
Astrid A. M. van der Veldt et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
Maxine Sun et al.
EUROPEAN UROLOGY (2011)
Development of c-MET pathway inhibitors
Xiangdong Liu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
High Jagged1 Expression Predicts Poor Outcome in Clear Cell Renal Cell Carcinoma
Kerong Wu et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas
Ying Chen et al.
JOURNAL OF PATHOLOGY (2011)
Clinical Characteristics and Outcomes of Patients With Recurrence 5 Years After Nephrectomy for Localized Renal Cell Carcinoma
Ari Adamy et al.
JOURNAL OF UROLOGY (2011)
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
Jesus Garcia-Donas et al.
LANCET ONCOLOGY (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Toxicity as a Biomarker of Efficacy of Molecular Targeted Therapies: Focus on EGFR and VEGF Inhibiting Anticancer Drugs
Rodrigo Dienstmann et al.
ONCOLOGIST (2011)
Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma
D. Tsavachidou-Fenner et al.
ANNALS OF ONCOLOGY (2010)
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy
Toni K. Choueiri et al.
BJU INTERNATIONAL (2010)
Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatment
Jacques Tostain et al.
EUROPEAN JOURNAL OF CANCER (2010)
Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients
Stephanie G. C. Kroeze et al.
EUROPEAN JOURNAL OF CANCER (2010)
Inflammatory Protein Serum Amyloid A1 Marks a Subset of Conventional Renal Cell Carcinomas with Fatal Outcome
Claudia Paret et al.
EUROPEAN UROLOGY (2010)
Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
Alexander B. Stillebroer et al.
EUROPEAN UROLOGY (2010)
Thymidine phosphorylase as a prognostic factor in renal cell carcinoma
Peeter Padrik et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2010)
Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
Bradley C. Leibovich et al.
JOURNAL OF UROLOGY (2010)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell et al.
NATURE (2010)
Mapping the face in the somatosensory brainstem
Reha S. Erzurumlu et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review)
Sunao Shoji et al.
ONCOLOGY LETTERS (2010)
Histopathologic subtype-specific genomic profiles of renal cell carcinomas identified by high-resolution whole-genome single nucleotide polymorphism array analysis
Akira Yokomizo et al.
ONCOLOGY LETTERS (2010)
MicroRNAs in Cancer
Ramiro Garzon et al.
ANNUAL REVIEW OF MEDICINE (2009)
Expression of potential molecular markers in renal cell carcinoma: impact on clinicopathological outcomes in patients undergoing radical nephrectomy
Iori Sakai et al.
BJU INTERNATIONAL (2009)
Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy
Tobias Klatte et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
MicroRNAs: Novel Biomarkers for Human Cancer
Claudine L. Bartels et al.
CLINICAL CHEMISTRY (2009)
Metastin Inhibits Migration and Invasion of Renal Cell Carcinoma with Overexpression of Metastin Receptor
Sunao Shoji et al.
EUROPEAN UROLOGY (2009)
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
Marianna Sabatino et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hypoxia inducible factor-1α correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma
Gordana Orevic et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
CA9 Gene: Single Nucleotide Polymorphism Predicts Metastatic Renal Cell Carcinoma Prognosis
Michela de Martino et al.
JOURNAL OF UROLOGY (2009)
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
Ondrej Slaby et al.
MOLECULAR CANCER (2009)
INNOVATION Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
Brian D. Brown et al.
NATURE REVIEWS GENETICS (2009)
Phosphorylation of ERK1/2 and Prognosis of Clear Cell Renal Cell Carcinoma
Hyun Ju Lee et al.
UROLOGY (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
The role of metastasis, suppressor genes in metastatic dormancy
Christine E. Horak et al.
APMIS (2008)
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma
Nathan E. Hoffmann et al.
CANCER (2008)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
Genetic and epigenetic alterations in the von Hippel-Lindau gene: The influence on renal cancer prognosis
Kim M. Smits et al.
CLINICAL CANCER RESEARCH (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
Jean-Jacques Patard et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo
Jonas Sjolund et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma
Brian I. Rini et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial
Tim Eisen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer
Guorong Li et al.
JOURNAL OF UROLOGY (2008)
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma
Toni K. Choueiri et al.
JOURNAL OF UROLOGY (2008)
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma
Tobias Klatte et al.
JOURNAL OF UROLOGY (2008)
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Charles G. Mullighan et al.
SCIENCE (2008)
Mathematical models for prognostic prediction in patients with renal cell carcinoma
Antonio Galfano et al.
UROLOGIA INTERNATIONALIS (2008)
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
Akeila Bellahcene et al.
NATURE REVIEWS CANCER (2008)
Hypoxia-inducible factor 1α in clear cell renal cell carcinoma
Tobias Klatte et al.
CLINICAL CANCER RESEARCH (2007)
Challenges of cancer biomarker profiling
Karim Bensalah et al.
EUROPEAN UROLOGY (2007)
Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma
Johanna Sandlund et al.
BJU INTERNATIONAL (2007)
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma
Daniel Cho et al.
CLINICAL GENITOURINARY CANCER (2007)
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
Toni K. Choueiri et al.
CANCER (2007)
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins
Samuel E. DePrimo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Prognostic relevance of the mTOR pathway in renal cell carcinoma - Implications for molecular patient selection for targeted therapy
Allan J. Pantuck et al.
CANCER (2007)
Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma
Nozomu Kawata et al.
UROLOGY (2007)
Multi-institutional validation of a new renal cancer-specific survival nomogram
Pierre I. Karakiewicz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy
Jose A. Karam et al.
LANCET ONCOLOGY (2007)
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
William G. Kaelin
CLINICAL CANCER RESEARCH (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role
Yasuyoshi Miyata et al.
EUROPEAN UROLOGY (2007)
CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy
Guorong Li et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: Prognostic implications and clinical significance for invasion and metastasis
Yasuyoshi Miyata et al.
CLINICAL CANCER RESEARCH (2006)
Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients
Vincent Hupertan et al.
CANCER (2006)
MicroRNA expression and function in cancer
Ramiro Garzon et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Rising incidence of small renal masses: A need to reassess treatment effect
John M. Hollingsworth et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Biologic significance of fascin expression in clear cell renal cell carcinoma: Systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique
Richard Zigeuner et al.
UROLOGY (2006)
High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma
Alexander S. Parker et al.
CANCER (2006)
Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma
M. Ugur Mungan et al.
EUROPEAN UROLOGY (2006)
Sunitinib in patients with metastatic renal cell carcinoma
Robert J. Motzer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors
Scott M. Gilbert et al.
UROLOGY (2006)
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
RH Thompson et al.
CANCER RESEARCH (2006)
Understanding the importance of smart drugs in renal cell carcinoma
JJ Patard et al.
EUROPEAN UROLOGY (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis
JD Pan et al.
JOURNAL OF IMMUNOLOGY (2006)
Renal cell carcinoma: Current status and future prospects
BJ Drucker
CANCER TREATMENT REVIEWS (2005)
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy -: A multicenter European study
L Cindolo et al.
CANCER (2005)
Clear cell renal cell carcinoma: Gene expression analyses identify a potential signature for tumor aggressiveness
F Kosari et al.
CLINICAL CANCER RESEARCH (2005)
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues
ACP Riddick et al.
BRITISH JOURNAL OF CANCER (2005)
Serum protein markers for early detection of ovarian cancer
G Mor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer
M Atkins et al.
CLINICAL CANCER RESEARCH (2005)
The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells
BS Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Prognostic value of histologic subtypes in renal cell carcinoma:: A multicenter experience
JJ Patard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment
M Toi et al.
LANCET ONCOLOGY (2005)
p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma
O Shvarts et al.
JOURNAL OF UROLOGY (2005)
Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma
S Fukata et al.
CANCER (2005)
Epithelial cell adhesion molecule (KSA) expression: Pathobiology and its role as an independent predictor of survival in renal cell carcinoma
DB Seligson et al.
CLINICAL CANCER RESEARCH (2004)
Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: A systematic analysis of primary and metastatic tumor tissue
R Zigeuner et al.
UROLOGY (2004)
Roles of fascin in cell adhesion and motility
JC Adams
CURRENT OPINION IN CELL BIOLOGY (2004)
Using protein expressions to predict survival in clear cell renal carcinoma
HL Kim et al.
CLINICAL CANCER RESEARCH (2004)
Pathways of apoptotic and non-apoptotic death in tumour cells
H Okada et al.
NATURE REVIEWS CANCER (2004)
B7-h1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression
J Konishi et al.
CLINICAL CANCER RESEARCH (2004)
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells
YE Latchman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL
P Staller et al.
NATURE (2003)
External validation is necessary in, prediction research: A clinical example
SE Bleeker et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Unmasking the S-phase-promoting potential of cyclin B1
JD Moore et al.
SCIENCE (2003)
The proteasome: structure, function, and role in the cell
J Adams
CANCER TREATMENT REVIEWS (2003)
Notch and cancer: Best to avoid the ups and downs
I Maillard et al.
CANCER CELL (2003)
Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin
E Svastova et al.
EXPERIMENTAL CELL RESEARCH (2003)
Vasculogenic mimicry and pseudo-comedo formation in breast cancer
K Shirakawa et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy
WK Lau et al.
UROLOGY (2002)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry
N Sharma et al.
PROSTATE (2002)
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
P Schraml et al.
JOURNAL OF PATHOLOGY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications
R Mathew et al.
CANCER DETECTION AND PREVENTION (2002)
Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor
T Ohtaki et al.
NATURE (2001)
Molecular determinants of ovarian cancer plasticity
AK Sood et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Assignment of TACSTD1 (alias TROP 1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization
G Calabrese et al.
CYTOGENETICS AND CELL GENETICS (2001)
Human tumour-associated cell adhesion protein MN/CA IX:: identification of M75 epitope and of the region mediating cell adhesion
J Závada et al.
BRITISH JOURNAL OF CANCER (2000)
Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions
Y Cao et al.
VIRCHOWS ARCHIV (2000)
Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states
S Urieli-Shoval et al.
CURRENT OPINION IN HEMATOLOGY (2000)
Vascular endothelial growth factor as prognostic factor in renal cell carcinoma
J Jacobsen et al.
JOURNAL OF UROLOGY (2000)
分享论文
